Scarica l'app Stockscreener
3.94
2.35%
-0.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GERN Giù?
Forum
Previsione
Precedente Chiudi:
$4.04
Aprire:
$4
Volume 24 ore:
988.38K
Relative Volume:
0.12
Capitalizzazione di mercato:
$2.45B
Reddito:
$29.48M
Utile/perdita netta:
$-201.19M
Rapporto P/E:
-11.59
EPS:
-0.34
Flusso di cassa netto:
$-216.50M
1 W Prestazione:
-2.83%
1M Prestazione:
-4.01%
6M Prestazione:
+3.00%
1 anno Prestazione:
+98.24%
Intervallo 1D:
$3.93
$4.02
Intervallo di 1 settimana:
$3.93
$4.205
Portata 52W:
$1.64
$5.34
Geron Corp Stock (GERN) Company Profile
Nome
Geron Corp
Settore
Industria
Telefono
(650) 473-7700
Indirizzo
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Confronta GERN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
3.94 | 2.45B | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.30 | 119.71B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.96 | 82.77B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
615.47 | 37.02B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.01 | 32.26B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.53 | 28.24B | 3.30B | -501.07M | 1.03B | -2.1146 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-05 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-09-09 | Iniziato | Leerink Partners | Outperform |
| 2024-04-30 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Iniziato | TD Cowen | Buy |
| 2024-03-15 | Reiterato | Needham | Buy |
| 2023-09-12 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-03-28 | Iniziato | Goldman | Neutral |
| 2022-10-28 | Iniziato | Wedbush | Outperform |
| 2022-07-28 | Ripresa | B. Riley Securities | Buy |
| 2021-11-02 | Iniziato | Robert W. Baird | Outperform |
| 2021-02-18 | Ripresa | B. Riley Securities | Buy |
| 2020-08-03 | Iniziato | Stifel | Buy |
| 2019-11-19 | Ripresa | B. Riley FBR | Buy |
| 2019-09-03 | Iniziato | H.C. Wainwright | Buy |
| 2019-08-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Aggiornamento | Needham | Hold → Buy |
| 2019-01-31 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Reiterato | FBR & Co. | Outperform |
| 2016-09-13 | Reiterato | FBR Capital | Outperform |
| 2015-12-07 | Reiterato | Piper Jaffray | Overweight |
| 2015-04-21 | Iniziato | Oppenheimer | Outperform |
| 2014-06-12 | Aggiornamento | MLV & Co | Hold → Buy |
| 2014-03-12 | Downgrade | MLV & Co | Buy → Hold |
| 2013-12-10 | Reiterato | MLV & Co | Buy |
| 2013-12-10 | Aggiornamento | Needham | Hold → Buy |
| 2013-11-08 | Reiterato | MLV & Co | Buy |
| 2013-10-16 | Iniziato | MLV & Co | Buy |
| 2012-08-30 | Iniziato | Stifel Nicolaus | Buy |
| 2012-06-28 | Iniziato | Needham | Hold |
Mostra tutto
Geron Corp Borsa (GERN) Ultime notizie
Geron Co. (NASDAQ:GERN) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Walleye Capital LLC Invests $7.52 Million in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron (NASDAQ:GERN) Trading Down 3.1%Here's What Happened - MarketBeat
Vestal Point Capital LP Takes $4.77 Million Position in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron Co. (NASDAQ:GERN) Shares Sold by Ally Bridge Group NY LLC - MarketBeat
Acuta Capital Partners LLC Acquires New Shares in Geron Co. (NASDAQ:GERN) - MarketBeat
Intech Investment Management LLC Takes Position in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron Co. (NASDAQ:GERN) Shares Purchased by Algert Global LLC - MarketBeat
Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Yahoo Finance
Geron Corp. (GERN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
12 NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
Geron Grants 1M Stock Options to New Hires at $3.99 Exercise Price | GERN Stock News - StockTitan
Geron: A Strong Launch And Financial Deals Make It Attractive (NASDAQ:GERN) - Seeking Alpha
Akin Advises Pharmakon Advisors in its $250 Million Debt Financing for Geron Corporation - Akin Gump Strauss Hauer & Feld LLP
First Turn Management LLC Takes $14.19 Million Position in Geron Co. (NASDAQ:GERN) - MarketBeat
RA Capital Management's Strategic Acquisition of Geron Corp Shar - GuruFocus.com
Deep Track Capital's Strategic Reduction in Geron Corp Holdings - GuruFocus.com
RTW INVESTMENTS, LP Acquires New Stake in Geron Corp - GuruFocus.com
GERNGeron Corp Latest Stock News & Market Updates - StockTitan
Geron's SWOT analysis: oncology biotech stock poised for growth - Investing.com
Geron Strengthens Leadership: Top Oncology Expert Dr. Eid Joins as EVP of R&D | GERN Stock News - StockTitan
Geron to Present at Stifel 2024 Healthcare ConferenceKey Management Insights Coming | GERN Stock News - StockTitan
B. Riley Predicts Geron's FY2026 Earnings (NASDAQ:GERN) - MarketBeat
Equities Analysts Offer Predictions for Geron Q2 Earnings - MarketBeat
HC Wainwright Weighs in on Geron's Q1 Earnings (NASDAQ:GERN) - MarketBeat
Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Q3 2024 Earnings Call Transcript - Insider Monkey
Geron Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ... By GuruFocus - Investing.com Canada
Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytel - GuruFocus.com
Geron Secures $250M Funding and Strong Q3 Sales - Yahoo Finance
Geron Corporation’s Q3 2024: Strong RYTELO Launch and Financial Growth - TipRanks
Geron started at buy by H.C. Wainwright ahead of Q3 earnings - MSN
Geron: Q3 Earnings Snapshot - Houston Chronicle
Geron (GERN) Q3 2024 Earnings Call Transcript - Barchart
Geron (NASDAQ:GERN) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Geron: A Post Earnings And Funding Announcement Assessment (NASDAQ:GERN) - Seeking Alpha
Geron earnings beat by $0.04, revenue topped estimates - Investing.com
Royalty Pharma to acquire royalty interest in Geron’s RYTELO for $125M - TipRanks
Geron price target raised to $9 from $8 at H.C. Wainwright - TipRanks
Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Geron spikes after Q3 beat and $375M funding deal - MSN
Geron sees FY24 operating expenses $260M-$270M - TipRanks
What is HC Wainwright's Estimate for Geron Q4 Earnings? - MarketBeat
Geron secures up to $375 million in financing - Investing.com
Geron stock spikes on Q3 beat and funding deal (GERN:NASDAQ) - Seeking Alpha
Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Geron’s (GERN) RYTELO for $125M - StreetInsider.com
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million - StockTitan
Geron Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Bakersfield Californian
Geron Secures Massive $375M Financing Deal for RYTELO Launch, Backed by Royalty Pharma | GERN Stock News - StockTitan
Geron Corp Azioni (GERN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.03%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):